Global Peptic Ulcer Drugs Market by Peptic Ulcer Type (Duodenal Ulcer, Gastric Ulcer), Drug Type (Cytoprotective Agents, H2 Blockers, Proton Pump Inhibitors (PPIs)), Distribution Channel - Forecast 2024-2030- Product Image

Sale

Global Peptic Ulcer Drugs Market by Peptic Ulcer Type (Duodenal Ulcer, Gastric Ulcer), Drug Type (Cytoprotective Agents, H2 Blockers, Proton Pump Inhibitors (PPIs)), Distribution Channel - Forecast 2024-2030

Report
189 Pages
March 2024
Region: Global
360iResearch™
ID: 5889038

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Peptic Ulcer Drugs Market size was estimated at USD 4.51 billion in 2023, USD 4.73 billion in 2024, and is expected to grow at a CAGR of 5.19% to reach USD 6.43 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Peptic Ulcer Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Peptic Ulcer Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Peptic Ulcer Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Century Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. LTD., Dr. Reddy’s Laboratories Ltd, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Medopharm Pvt Ltd, Merck KGaA, Mylan N.V., Novartis AG, Pfizer Inc., Pharmanova India Drugs Pvt. Ltd., Redhill Biopharma Ltd, Rosemont Pharmaceuticals Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ulcerex Pharma, USAntibiotics, and Yuhan Corporation.

Market Segmentation & Coverage

This research report categorizes the Peptic Ulcer Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Peptic Ulcer Type
- Duodenal Ulcer
- Gastric Ulcer
Drug Type
- Cytoprotective Agents
- H2 Blockers
- Proton Pump Inhibitors (PPIs)
Distribution Channel
- Offline
  - Hospitals
  - Retail Pharmacies
- Online

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Peptic Ulcer Drugs Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Peptic Ulcer Drugs Market?
What are the technology trends and regulatory frameworks in the Peptic Ulcer Drugs Market?
What is the market share of the leading vendors in the Peptic Ulcer Drugs Market?
Which modes and strategic moves are suitable for entering the Peptic Ulcer Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Peptic Ulcer Drugs Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of peptic ulcers with expanding geriatric population
5.1.1.2. Growing awareness about peptic ulcers and advancements in diagnostic techniques
5.1.1.3. Increasing emphasis on patient-centric care and personalized peptic ulcer treatment
5.1.2. Restraints
5.1.2.1. High cost of peptic ulcer drugs
5.1.3. Opportunities
5.1.3.1. Introduction of newer and effective peptic ulcer drugs
5.1.3.2. Growing adoption of telemedicine and e-commerce platforms
5.1.4. Challenges
5.1.4.1. Adverse effects associated with peptic ulcer drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Peptic Ulcer Drugs Market, by Peptic Ulcer Type

6.1. Introduction
6.2. Duodenal Ulcer
6.3. Gastric Ulcer

7. Peptic Ulcer Drugs Market, by Drug Type

7.1. Introduction
7.2. Cytoprotective Agents
7.3. H2 Blockers
7.4. Proton Pump Inhibitors (PPIs)

8. Peptic Ulcer Drugs Market, by Distribution Channel

8.1. Introduction
8.2. Offline
8.3.1. Hospitals
8.3.2. Retail Pharmacies
8.3. Online

9. Americas Peptic Ulcer Drugs Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Peptic Ulcer Drugs Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Peptic Ulcer Drugs Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. AbbVie Inc.
13.1.3. AstraZeneca PLC
13.1.4. Boehringer Ingelheim International GmbH
13.1.5. Cadila Healthcare Ltd.
13.1.6. Century Pharmaceuticals Ltd.
13.1.7. Daewoong Pharmaceutical Co. LTD.
13.1.8. Dr. Reddy’s Laboratories Ltd
13.1.9. Eisai Co. Ltd.
13.1.10. F. Hoffmann-La Roche Ltd.
13.1.11. GlaxoSmithKline PLC
13.1.12. Hikma Pharmaceuticals PLC
13.1.13. Medopharm Pvt Ltd
13.1.14. Merck KGaA
13.1.15. Mylan N.V.
13.1.16. Novartis AG
13.1.17. Pfizer Inc.
13.1.18. Pharmanova India Drugs Pvt. Ltd.
13.1.19. Redhill Biopharma Ltd
13.1.20. Rosemont Pharmaceuticals Limited
13.1.21. Takeda Pharmaceutical Company Limited
13.1.22. Teva Pharmaceutical Industries Ltd.
13.1.23. Ulcerex Pharma
13.1.24. USAntibiotics
13.1.25. Yuhan Corporation
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. PEPTIC ULCER DRUGS MARKET RESEARCH PROCESS
FIGURE 2. PEPTIC ULCER DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. PEPTIC ULCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. PEPTIC ULCER DRUGS MARKET DYNAMICS
FIGURE 7. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2023 VS 2030 (%)
FIGURE 8. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 10. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. PEPTIC ULCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. PEPTIC ULCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. PEPTIC ULCER DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. PEPTIC ULCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 6. PEPTIC ULCER DRUGS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PEPTIC ULCER DRUGS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 9. PEPTIC ULCER DRUGS MARKET SIZE, BY CYTOPROTECTIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PEPTIC ULCER DRUGS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PEPTIC ULCER DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS (PPIS), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 13. PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 15. PEPTIC ULCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PEPTIC ULCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PEPTIC ULCER DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 31. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 53. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 54. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 57. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 58. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 59. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 65. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 66. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 77. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 89. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 90. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 91. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 93. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 103. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 106. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 107. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 108. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 110. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 111. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 114. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 115. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 118. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 126. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 127. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 130. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 138. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 139. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 142. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 143. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 144. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 146. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 147. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 148. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 162. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 163. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 174. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 175. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 186. PEPTIC ULCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 187. PEPTIC ULCER DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 188. PEPTIC ULCER DRUGS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
AbbVie Inc.
AstraZeneca PLC
Boehringer Ingelheim International GmbH
Cadila Healthcare Ltd.
Century Pharmaceuticals Ltd.
Daewoong Pharmaceutical Co. LTD.
Dr. Reddy’s Laboratories Ltd
Eisai Co. Ltd.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline PLC
Hikma Pharmaceuticals PLC
Medopharm Pvt Ltd
Merck KGaA
Mylan N.V.
Novartis AG
Pfizer Inc.
Pharmanova India Drugs Pvt. Ltd.
Redhill Biopharma Ltd
Rosemont Pharmaceuticals Limited
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.
Ulcerex Pharma
USAntibiotics
Yuhan Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 4.73 Billion
Forecasted Market Value ( USD ) by 2030	$ 6.43 Billion
Compound Annual Growth Rate	5.1%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Peptic Ulcer Drugs - Global Strategic Business Report

Peptic Ulcer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

Anti Peptic Ulcer Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

Proton Pump Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

Proton Pump Inhibitors Global Market Report 2024

About the Peptic Ulcer Drug Market